Muhammad Aslam, MD
Interventional Cardiology · South Bend, INNPI 1023053022
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,121 of the $13,615 with a category attached, or 67.0%. It is spread thinly across 36 manufacturers, the largest accounting for just 20.6%. Reporting peaked in 2022 at $3,715 and has fallen 53.7% since, to $1,720 in 2025.
Across 298 payments — averaging $45.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Edwards Lifesciences$3K
- Abbott$2K
- Medtronic$1K
- Shockwave Medical, Inc$1K
- Novartis$833
- plus $3K from 30 others
Across 2 payments — averaging $2482.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$5K
What the payments were for
- Travel & lodging$4,47233%
- Food & beverage$9,12167%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $2,805 |
| Edwards Lifesciences | 25 | $2,627 |
| Abbott | 25 | $2,336 |
| Medtronic(3 entities) | 30 | $1,287 |
| Shockwave Medical, Inc | 33 | $1,075 |
| Novartis | 53 | $833 |
| Abiomed | 12 | $621 |
| Johnson & Johnson | 26 | $225 |
| Amgen | 9 | $162 |
| Cvrx, Inc. | 2 | $155 |
| Merck | 7 | $149 |
| Inari Medical, Inc. | 1 | $124 |
| Cardiovascular Systems Inc. | 5 | $120 |
| Penumbra, Inc. | 5 | $117 |
| Sanofi-aventis U.S. LLC | 2 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $111 |
| Cardiva Medical, Inc. | 3 | $109 |
| Pfizer | 7 | $103 |
| AstraZeneca | 5 | $70 |
| Laborie Medical Technologies Corp. | 1 | $67 |
| Philips North America LLC | 2 | $50 |
| Actelion Pharmaceuticals US, Inc. | 3 | $40 |
| Boehringer Ingelheim | 2 | $38 |
| United Therapeutics Corporation | 1 | $32 |
| Chiesi USA, Inc. | 1 | $28 |
| Vifor Pharma, Inc. | 1 | $24 |
| Amryt Pharma Holdings Ltd | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Tempus AI, Inc | 1 | $20 |
| Cordis US CORP. | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $19 |
| EKOS Corporation | 1 | $17 |
| Getinge USA Sales, LLC | 1 | $16 |
| Elutia, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VersaCross Access Solution$1,375
- AMPLATZER AMULET$1,311
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,036
- THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM$739
- WATCHMAN Access System$670
- SAPIEN 3 Ultra RESILIA$268
- MitraClip System$259
- Impella$237
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$210
- INTERSTIM$162
- SYMPLICITY G3$151
- ENSITE PRECISION$149
- RESOLUTE ONYX$140
- Barostim Neo System$138
- General - Balloon Catheters$132
- WATCHMAN FLX$129
- FLOWTRIEVER CATHETER, S$124
- CT THROMBECTOMY SYSTEM KIT$124
- AVVIGO Guidance System$114
- COREVALVE EVOLUT R$101
How this compares
$13,615 in reported general payments places this provider in the 70th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 365 | $418,914 |
| EntrestoSacubitril/Valsartan | 134 | $153,244 |
| XareltoRivaroxaban | 59 | $76,448 |
| Repatha SureclickEvolocumab | 70 | $67,401 |
| BrilintaTicagrelor | 80 | $47,638 |
| FarxigaDapagliflozin Propanediol | 34 | $37,516 |
| JardianceEmpagliflozin | 20 | $24,576 |
| Praluent PenAlirocumab | 21 | $15,583 |
| Atorvastatin Calcium | 1,161 | $8,883 |
| Dofetilide | 50 | $8,077 |
| Metoprolol Succinate | 668 | $6,146 |
| Ezetimibe | 294 | $5,365 |
| ClopidogrelClopidogrel Bisulfate | 652 | $5,118 |
| Potassium Chloride | 294 | $4,394 |
| Losartan Potassium | 513 | $4,188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $103 | $418,914365 claims |
| NovartisEntresto | $833 | $153,244134 claims |
| AstraZenecaBrilinta, Farxiga | $70 | $85,154114 claims |
| Johnson & JohnsonXarelto | $225 | $76,44859 claims |
| Boehringer IngelheimJardiance | $38 | $24,57620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in South Bend
- Mayank MittalSouth Bend$43K
- Khalid NajibSouth Bend$26K
- Waseem BarhamSouth Bend$13K
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Muzammil MusaniFort Wayne$184K
- Dean FerreraEast Chicago$180K
- Shashidhar DivakaruniMunster$97K
- Jarrod FrizzellEvansville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.